「すべてのCookieを受け入れる」をクリックすると、サイトのナビゲーション向上、サイト利用状況の分析、 およびマーケティング活動の支援のために、お使いのデバイスにCookieを保存することに同意したものとみなされます。
プライバシーポリシー???????CDMO??????????????????????????????????????????????????????????????????????LAMEA????????????????????????? 2026???2035?
??????????CDMO???2025??25??????????2035?????53?5000???????????????????????????CAGR?7.90?????????????????????????????????????????????????????????????????
| ?????? | ?? |
| 2025?????? | 25???? |
| 2026?????? | 27???? |
| 2032?????? | 42?6000???? |
| 2035???????? | 53?5,000???? |
| 2026???2035?????????? | 7.90% |
| ??? | 2025? |
| ???? | 2026???2035? |
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
| ????? | ?????? |
| ?? | 45% |
| ?? | 25% |
| ?????? | 20% |
| LAMEA | 10% |
| ????? | ????%? |
| ???? | 60% |
| ????????? | 40% |
| ????? | ????%? |
| ???? | 70% |
| ?????? | 30% |
| ????? | ????%? |
| ??? | 60% |
| ??????? | 40% |
発行元 Yogesh Kulkarni
| Product Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Therapy | 1.50 | 1.61 | 1.74 | 1.87 | 2.03 | 2.19 | 2.36 | 2.54 | 2.74 | 2.97 | 3.20 |
| Gene-Modified Cell Therapy | 1 | 1.08 | 1.16 | 1.25 | 1.35 | 1.46 | 1.57 | 1.69 | 1.82 | 1.97 | 2.12 |
| Service Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Manufacturing | 1.75 | 1.88 | 2.03 | 2.19 | 2.36 | 2.54 | 2.74 | 2.95 | 3.19 | 3.45 | 3.74 |
| Process Development | 0.75 | 0.81 | 0.87 | 0.94 | 1.02 | 1.10 | 1.18 | 1.28 | 1.38 | 1.48 | 1.61 |
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.13 | 1.22 | 1.31 | 1.42 | 1.53 | 1.66 | 1.79 | 1.93 | 2.08 | 2.24 | 2.43 |
| Europe | 0.63 | 0.68 | 0.73 | 0.79 | 0.85 | 0.92 | 1.00 | 1.07 | 1.16 | 1.24 | 1.35 |
| Asia Pacific | 0.50 | 0.54 | 0.58 | 0.63 | 0.68 | 0.74 | 0.79 | 0.86 | 0.93 | 1.00 | 1.07 |
| LAMEA | 0.25 | 0.27 | 0.29 | 0.31 | 0.34 | 0.37 | 0.40 | 0.43 | 0.46 | 0.50 | 0.54 |
| サブセグメント | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Therapy | 1.50 | 1.61 | 1.74 | 1.87 | 2.03 | 2.19 | 2.36 | 2.54 | 2.74 | 2.97 | 3.20 |
| Gene-Modified Cell Therapy | 1 | 1.08 | 1.16 | 1.25 | 1.35 | 1.46 | 1.57 | 1.69 | 1.82 | 1.97 | 2.12 |
| サブセグメント | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Manufacturing | 1.75 | 1.88 | 2.03 | 2.19 | 2.36 | 2.54 | 2.74 | 2.95 | 3.19 | 3.45 | 3.74 |
| Process Development | 0.75 | 0.81 | 0.87 | 0.94 | 1.02 | 1.10 | 1.18 | 1.28 | 1.38 | 1.48 | 1.61 |
| サブセグメント | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.13 | 1.22 | 1.31 | 1.42 | 1.53 | 1.66 | 1.79 | 1.93 | 2.08 | 2.24 | 2.43 |
| Europe | 0.63 | 0.68 | 0.73 | 0.79 | 0.85 | 0.92 | 1.00 | 1.07 | 1.16 | 1.24 | 1.35 |
| Asia Pacific | 0.50 | 0.54 | 0.58 | 0.63 | 0.68 | 0.74 | 0.79 | 0.86 | 0.93 | 1.00 | 1.07 |
| LAMEA | 0.25 | 0.27 | 0.29 | 0.31 | 0.34 | 0.37 | 0.40 | 0.43 | 0.46 | 0.50 | 0.54 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.